Votrient 200 MG tablet 120S
Ended Awarded
- Contract number
- SPE2DB25FJQ14
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $22,956
Award facts
- Contract value 100% obligated
- $22,955.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Votrient 200 mg tablets (120-count units) valued at $22,955.92 with a firm fixed price structure. This delivery order represents a competitive award with no set-aside designation and is scheduled for completion by September 16, 2025, with fulfillment occurring from the vendor's location in Conshohocken, Pennsylvania. Votrient is a brand-name oncology medication used in cancer treatment, reflecting the Defense Logistics Agency's critical role in supplying pharmaceutical products to support military and veteran healthcare systems.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical support vehicle extending through December 2026. The parent contract enables AmerisourceBergen to supply a comprehensive range of medications and medical supplies to the Defense Health Agency and other federal healthcare customers worldwide. As a major pharmaceutical distributor and established federal vendor, AmerisourceBergen Drug Corp maintains a significant portfolio of competitively awarded contracts with DLA for various therapeutic products, positioning the company as a key supplier within the military healthcare supply chain.
Quick answers
Who was awarded contract SPE2DB25FJQ14?
SPE2DB25FJQ14 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 25, 2025.
How much is contract SPE2DB25FJQ14 worth?
The government has obligated $22,956 on SPE2DB25FJQ14.
Is contract SPE2DB25FJQ14 an order under another contract?
Yes. SPE2DB25FJQ14 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FJQ14 competed?
The extent of competition for SPE2DB25FJQ14 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award